90% concordance with tumor board recommendations on breast cancer
Manipal Hospitals put Watson to the test, comparing the evidence-based recommendations of Watson for Oncology to that of Manipal’s tumor board (the team of 12-15 cancer specialists who review the most complex cancer cases each week). In a double-blinded study, the doctors at Manipal found that Watson was concordant with the tumor board recommendations in 90 percent of cases breast cancer. The study was presented at the San Antonio Breast Cancer Symposium.
*Source: Presentation by Prof. Dr. S.P. Somashekhar, Chairman, Manipal Comprehensive Cancer Center, Manipal Hospitals, Bangalore, India at the San Antonio Breast Cancer Symposium, December 9th, 2016